{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T14:28:33Z","timestamp":1787668113483,"version":"build-2736575974"},"reference-count":47,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.phrs.2011.05.011","type":"journal-article","created":{"date-parts":[[2011,6,5]],"date-time":"2011-06-05T19:31:25Z","timestamp":1307302285000},"page":"595-601","source":"Crossref","is-referenced-by-count":23,"title":["Chemically modified tetracycline-3 (CMT-3): A novel inhibitor of the serine proteinase, elastase"],"prefix":"10.1016","volume":"64","author":[{"given":"Ying","family":"Gu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsi-Ming","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanford R.","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorne M.","family":"Golub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.phrs.2011.05.011_bib0005","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1177\/08959374980120010501","article-title":"Tetracyclines inhibit connective tissue breakdown by multiple non-antimicrobial mechanisms","volume":"2","author":"Golub","year":"1998","journal-title":"Adv Dent Res"},{"issue":"1","key":"10.1016\/j.phrs.2011.05.011_bib0010","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.semcdb.2007.07.003","article-title":"Matrix metalloproteinases as modulators of inflammation","volume":"19","author":"Manicone","year":"2008","journal-title":"Semin Cell Dev Biol"},{"issue":"7","key":"10.1016\/j.phrs.2011.05.011_bib0015","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nri1841","article-title":"Neutrophil serine proteases: specific regulators of inflammation","volume":"6","author":"Pham","year":"2006","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"10.1016\/j.phrs.2011.05.011_bib0020","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1600-0609.1997.tb00940.x","article-title":"Biosynthesis, processing and sorting of neutrophil proteins: insight into neutrophil granule development","volume":"58","author":"Gullberg","year":"1997","journal-title":"Eur J Haematol"},{"issue":"14","key":"10.1016\/j.phrs.2011.05.011_bib0025","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.micinf.2003.09.008","article-title":"Neutrophil granules and secretory vesicles in inflammation","volume":"5","author":"Faurschou","year":"2003","journal-title":"Microbes Infect"},{"issue":"2","key":"10.1016\/j.phrs.2011.05.011_bib0030","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.bbamcr.2004.05.008","article-title":"Plasma membrane targeting of exocytic SNARE proteins","volume":"1693","author":"Sala\u00fcn","year":"2004","journal-title":"Biochim Biophys Acta"},{"issue":"6884","key":"10.1016\/j.phrs.2011.05.011_bib0035","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/417091a","article-title":"Neutrophil elastase targets virulence factors of enterobacteria","volume":"417","author":"Weinrauch","year":"2002","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.phrs.2011.05.011_bib0040","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1365-2796.2005.01476.x","article-title":"Neutrophil serine proteases: potential key regulators of cell signalling during inflammation","volume":"257","author":"Wiedow","year":"2005","journal-title":"J Intern Med"},{"issue":"3","key":"10.1016\/j.phrs.2011.05.011_bib0045","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1083\/jcb.131.3.775","article-title":"Cell surface-bound elastase and cathepsin G on human neutrophils: a novel, non-oxidative mechanism by which neutrophils focus and preserve catalytic activity of serine proteinases","volume":"131","author":"Owen","year":"1995","journal-title":"J Cell Biol"},{"issue":"1","key":"10.1016\/j.phrs.2011.05.011_bib0050","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1042\/CS20050115","article-title":"SLPI and elafin: one glove, many fingers","volume":"110","author":"Williams","year":"2006","journal-title":"Clin Sci (Lond)"},{"issue":"2","key":"10.1016\/j.phrs.2011.05.011_bib0055","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.biochi.2007.09.007","article-title":"Multifaceted roles of human elafin and secretory leukocyte proteinase inhibitor (SLPI), two serine protease inhibitors of the chelonianin family","volume":"90","author":"Moreau","year":"2008","journal-title":"Biochimie"},{"issue":"2","key":"10.1016\/j.phrs.2011.05.011_bib0060","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1172\/JCI115021","article-title":"Anti-neutrophil elastase defense of the normal human respiratory epithelial surface provided by the secretory leukoprotease inhibitor","volume":"87","author":"Vogelmeier","year":"1991","journal-title":"Clin Invest"},{"issue":"36","key":"10.1016\/j.phrs.2011.05.011_bib0065","doi-asserted-by":"crossref","first-page":"33345","DOI":"10.1074\/jbc.M103220200","article-title":"Cathepsin B, L, and S cleave and inactivate secretory leucoprotease inhibitor","volume":"276","author":"Taggart","year":"2001","journal-title":"J Biol Chem"},{"issue":"25","key":"10.1016\/j.phrs.2011.05.011_bib0070","doi-asserted-by":"crossref","first-page":"14791","DOI":"10.1016\/S0021-9258(18)77182-2","article-title":"Elafin: an elastase-specific inhibitor of human skin. Purification, characterization, and complete amino acid sequence","volume":"265","author":"Wiedow","year":"1990","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.phrs.2011.05.011_bib0075","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1515\/bchm3.1991.372.1.13","article-title":"Purification and characterization of elastase-specific inhibitor. Sequence homology with mucus proteinase inhibitor","volume":"372","author":"Sallenave","year":"1991","journal-title":"Biol Chem Hoppe Seyler"},{"issue":"4 Pt 1","key":"10.1016\/j.phrs.2011.05.011_bib0080","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1164\/ajrccm.154.4.8887613","article-title":"Elafin\/elastase-specific inhibitor in bronchoalveolar lavage of normal subjects and farmer's lung","volume":"154","author":"Tremblay","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.phrs.2011.05.011_bib0085","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0002-9440(10)65270-4","article-title":"Inhibition of NF-kappaB activation and augmentation of IkappaBbeta by secretory leukocyte protease inhibitor during lung inflammation","volume":"154","author":"Lentsch","year":"1999","journal-title":"Am J Pathol"},{"issue":"4","key":"10.1016\/j.phrs.2011.05.011_bib0090","first-page":"225","article-title":"Alpha-1-antitrypsin globules in liver biopsies","volume":"88","author":"Clausen","year":"1980","journal-title":"Acta Pathol Microbiol Scand A"},{"issue":"20","key":"10.1016\/j.phrs.2011.05.011_bib0095","doi-asserted-by":"crossref","first-page":"6918","DOI":"10.1073\/pnas.82.20.6918","article-title":"The cellular defect in alpha 1-proteinase inhibitor (alpha 1-PI) deficiency is expressed in human monocytes and in Xenopus oocytes injected with human liver mRNA","volume":"82","author":"Perlmutter","year":"1985","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"10.1016\/j.phrs.2011.05.011_bib0100","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1172\/JCI112524","article-title":"Expression of the alpha-1-antitrypsin gene in mononuclear phagocytes of normal and alpha-1-antitrypsin-deficient individuals","volume":"77","author":"Mornex","year":"1986","journal-title":"J Clin Invest"},{"issue":"9","key":"10.1016\/j.phrs.2011.05.011_bib0105","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1002\/j.1460-2075.1987.tb02571.x","article-title":"The human alpha 1-antitrypsin gene is transcribed from two different promoters in macrophages and hepatocytes","volume":"6","author":"Perlino","year":"1987","journal-title":"EMBO J"},{"issue":"1","key":"10.1016\/j.phrs.2011.05.011_bib0110","first-page":"1","article-title":"Acute phase proteins as disease markers","volume":"5","author":"Kushner","year":"1987","journal-title":"Dis Markers"},{"issue":"2","key":"10.1016\/j.phrs.2011.05.011_bib0115","first-page":"417","article-title":"Elastases and emphysema. Current assessment of the protease\u2013antiprotease hypothesis","volume":"132","author":"Janoff","year":"1985","journal-title":"Am Rev Respir Dis"},{"issue":"3","key":"10.1016\/j.phrs.2011.05.011_bib0120","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2340\/0001555571189194","article-title":"Use of anti-collagenase properties of doxycycline in treatment of alpha 1-antitrypsin deficiency panniculitis","volume":"71","author":"Humbert","year":"1991","journal-title":"Acta Derm Venereol"},{"issue":"7","key":"10.1016\/j.phrs.2011.05.011_bib0125","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1517\/13543784.11.7.965","article-title":"Neutrophil elastase inhibitors as treatment for COPD","volume":"11","author":"Ohbayashi","year":"2002","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.phrs.2011.05.011_bib0130","doi-asserted-by":"crossref","first-page":"395","DOI":"10.2174\/138920011795202901","article-title":"Matrix metalloproteinase inhibitors: a review on bioanalytical methods. Pharmacokinetics and metabolism","volume":"12","author":"Wang","year":"2011","journal-title":"Curr Drug Metab"},{"issue":"6","key":"10.1016\/j.phrs.2011.05.011_bib0135","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1189\/jlb.0607338","article-title":"Chemokine and cytokine processing by matrix metalloproteinases and its effect on leukocyte migration and inflammation","volume":"82","author":"Van Lint","year":"2007","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.phrs.2011.05.011_bib0140","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.2741\/2161","article-title":"The dual personalities of matrix metalloproteinases in inflammation","volume":"12","author":"Le","year":"2007","journal-title":"Front Biosci"},{"issue":"3","key":"10.1016\/j.phrs.2011.05.011_bib0145","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1177\/10454411910020030201","article-title":"Tetracyclines inhibit connective tissue breakdown: new therapeutic implications for an old family of drugs","volume":"2","author":"Golub","year":"1991","journal-title":"Crit Rev Oral Biol Med"},{"issue":"2","key":"10.1016\/j.phrs.2011.05.011_bib0150","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1177\/10454411930040020401","article-title":"Matrix metalloproteinase: a review","volume":"4","author":"Birkedal-Hansen","year":"1993","journal-title":"Crit Rev Oral Biol Med"},{"issue":"6","key":"10.1016\/j.phrs.2011.05.011_bib0155","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/00000441-199812000-00001","article-title":"Modulation of plasma metalloproteinase-9 concentrations and peripheral blood monocyte mRNA levels in patients with septic shock: effect of fiber-immobilized polymyxin B treatment","volume":"316","author":"Nakamura","year":"1998","journal-title":"Am J Med Sci"},{"issue":"8","key":"10.1016\/j.phrs.2011.05.011_bib0160","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1046\/j.1365-2044.2001.02083.x","article-title":"Matrix metalloproteinase-9 concentrations in critically ill patients","volume":"56","author":"Yassen","year":"2001","journal-title":"Anaesthesia"},{"issue":"5","key":"10.1016\/j.phrs.2011.05.011_bib0165","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/j.1600-0765.1983.tb00388.x","article-title":"Minocycline reduces gingival collagenolytic activity during diabetes. Preliminary observations and a proposed new mechanism of action","volume":"18","author":"Golub","year":"1983","journal-title":"J Periodontal Res"},{"key":"10.1016\/j.phrs.2011.05.011_bib0170","first-page":"80","article-title":"Host modulation with tetracyclines and their chemically modified analogues","volume":"2","author":"Golub","year":"1992","journal-title":"Curr Opin Dent"},{"issue":"3","key":"10.1016\/j.phrs.2011.05.011_bib0175","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2174\/0929867013373642","article-title":"Inhibition of tumor cell invasiveness by chemically modified tetracyclines","volume":"8","author":"Gu","year":"2001","journal-title":"Curr Med Chem"},{"issue":"6","key":"10.1016\/j.phrs.2011.05.011_bib0180","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1080\/07853890500300386","article-title":"Inhibition of breast cancer cell extracellular matrix degradative activity by chemically modified tetracyclines","volume":"37","author":"Gu","year":"2005","journal-title":"Ann Med"},{"issue":"2","key":"10.1016\/j.phrs.2011.05.011_bib0185","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/ijc.10168","article-title":"Inhibition of cell proliferation, invasion, tumor growth and metastasis by an oral non-antimicrobial tetracycline analog (COL-3) in a metastatic prostate cancer model","volume":"98","author":"Lokeshwar","year":"2002","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1016\/j.phrs.2011.05.011_bib0190","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1200\/JCO.20.1.153","article-title":"Matrix metalloproteinase inhibitor COL-3 in the treatment of AIDS-related Kaposi's sarcoma: a phase I AIDS malignancy consortium study","volume":"20","author":"Cianfrocca","year":"2002","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.phrs.2011.05.011_bib0195","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1200\/JCO.2001.19.2.584","article-title":"Phase I clinical trial of oral COL-3, a matrix metalloproteinase inhibitor, in patients with refractory metastatic cancer","volume":"19","author":"Rudek","year":"2001","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1016\/j.phrs.2011.05.011_bib0200","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1200\/JCO.2005.04.2614","article-title":"Randomized phase II trial of matrix metalloproteinase inhibitor COL-3 in AIDS-related Kaposi's sarcoma: an AIDS Malignancy Consortium Study","volume":"24","author":"Dezube","year":"2006","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.phrs.2011.05.011_bib0205","doi-asserted-by":"crossref","first-page":"163","DOI":"10.14219\/jada.archive.1994.0261","article-title":"Treating periodontal diseases by blocking tissue-destructive enzymes","volume":"125","author":"Golub","year":"1994","journal-title":"J Am Dent Assoc"},{"issue":"5","key":"10.1016\/j.phrs.2011.05.011_bib0210","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1021\/bi00431a001","article-title":"Human leukocyte and porcine pancreatic elastase: X-ray crystal structures, mechanism, substrate specificity, and mechanism-based inhibitors","volume":"28","author":"Bode","year":"1989","journal-title":"Biochemistry"},{"issue":"Pt 2","key":"10.1016\/j.phrs.2011.05.011_bib0215","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1042\/bj2770521","article-title":"Inhibition of human leucocyte elastase by ursolic acid. Evidence for a binding site for pentacyclic triterpenes","volume":"277","author":"Ying","year":"1991","journal-title":"Biochem J"},{"issue":"3","key":"10.1016\/j.phrs.2011.05.011_bib0220","first-page":"303","article-title":"Local and systemic factors in periodontal disease increase matrix-degrading enzyme activities in rat gingiva: effect of minocycline therapy","volume":"91","author":"Chang","year":"1996","journal-title":"Res Commun Mol Pathol Pharmacol"},{"issue":"4","key":"10.1016\/j.phrs.2011.05.011_bib0225","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/01.shk.0000180619.06317.2c","article-title":"Chemically modified tetracycline prevents the development of septic shock and acute respiratory distress syndrome in a clinically applicable porcine model","volume":"24","author":"Steinberg","year":"2005","journal-title":"Shock"},{"issue":"12","key":"10.1016\/j.phrs.2011.05.011_bib0230","first-page":"2675","article-title":"Chemically modified tetracycline (COL-3) improves survival if given 12 but not 24hours after cecal ligation and puncture","volume":"30","author":"Halter","year":"2002","journal-title":"Crit Care Med"},{"issue":"2","key":"10.1016\/j.phrs.2011.05.011_bib0235","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0022-4804(03)00089-1","article-title":"Metalloproteinase inhibition reduces lung injury and improves survival after cecal ligation and puncture in rats","volume":"111","author":"Steinberg","year":"2003","journal-title":"J Surg Res"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661811001484?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661811001484?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,7]],"date-time":"2024-04-07T09:47:43Z","timestamp":1712483263000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661811001484"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S1043661811001484"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2011.05.011","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}